ISCHEMIC CENTRAL RETINAL VEIN OCCLUSION IN THE ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ERA

20179 citationsJournal Article

Authors

Emily K. Tam · University of California, Los Angeles

Pamela R. Golchet

Madeline Yung · University of California, Los Angeles

Francis Char DeCroos · Southeastern Retina Associates

Marc J. Spirn · Wills Eye Hospital

Lydia Lehmann-Clarke · University of Lausanne

Aude Ambresin · University of Lausanne

Abstract

This study highlights significant variability in the use of anti-vascular endothelial growth factor therapy for ischemic CRVO and underscores that eyes with neovascularization tend to have worse visual outcomes.

Topics & Keywords

Retinal and Optic Conditions Retinal Diseases and Treatments Ocular Diseases and Behçet’s Syndrome

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Retina

Volume 38, Issue 2, pp. 292-298

DOI: 10.1097/iae.0000000000001546

Field-Weighted Citation Impact: 1.39